BioNexus Gene Lab Common Stock Net 2019-2025 | BGLC
BioNexus Gene Lab common stock net from 2019 to 2025. Common stock net can be defined as the value of common equity ownership.
| BioNexus Gene Lab Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $17 |
| 2023 | $17 |
| 2022 | $11 |
| 2021 | $11 |
| 2020 | $11 |
| 2019 | $6 |
| 2018 | $7 |
| BioNexus Gene Lab Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $17 |
| 2024-12-31 | $17 |
| 2024-09-30 | $17 |
| 2024-06-30 | $17 |
| 2024-03-31 | $17 |
| 2023-12-31 | $17 |
| 2023-09-30 | $17 |
| 2023-06-30 | $11 |
| 2023-03-31 | $11 |
| 2022-12-31 | $11 |
| 2022-09-30 | $11 |
| 2022-06-30 | $11 |
| 2022-03-31 | $11 |
| 2021-12-31 | $11 |
| 2021-09-30 | $11 |
| 2021-06-30 | $11 |
| 2021-03-31 | $11 |
| 2020-12-31 | $11 |
| 2020-09-30 | $6 |
| 2020-06-30 | $6 |
| 2020-03-31 | $6 |
| 2019-12-31 | $6 |
| 2019-09-30 | $7 |
| 2019-06-30 | $7 |
| 2019-03-31 | $7 |
| 2018-12-31 | $7 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.010B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.611B | 26.64 |
| CVS Health (CVS) | United States | $83.126B | 10.34 |
| Elevance Health (ELV) | United States | $66.200B | 8.90 |
| Cencora (COR) | United States | $55.265B | 18.41 |
| DiDi Global (DIDIY) | China | $26.074B | 27.70 |
| Labcorp Holdings (LH) | United States | $22.092B | 17.56 |
| Natera (NTRA) | United States | $20.748B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.860B | 0.00 |
| CochLear (CHEOY) | Australia | $13.234B | 0.00 |
| ICON (ICLR) | Ireland | $12.795B | 12.31 |
| Solventum (SOLV) | United States | $12.697B | 13.13 |
| Medpace Holdings (MEDP) | United States | $12.202B | 32.29 |
| Viatris (VTRS) | United States | $11.385B | 4.02 |
| Revvity (RVTY) | United States | $10.080B | 17.76 |
| Sonic Healthcare (SKHHY) | Australia | $8.961B | 0.00 |
| HealthEquity (HQY) | United States | $8.047B | 35.25 |
| Avantor (AVTR) | United States | $7.840B | 11.50 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.569B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.320B | 13.89 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 32.48 |
| Sotera Health (SHC) | United States | $3.965B | 22.17 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| BrightSpring Health Services (BTSG) | United States | $3.681B | 28.08 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| GeneDx Holdings (WGS) | United States | $3.020B | 69.16 |
| Alignment Healthcare (ALHC) | United States | $2.873B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 17.58 |
| Organon (OGN) | United States | $2.397B | 2.61 |
| Progyny (PGNY) | United States | $1.959B | 41.54 |
| Premier (PINC) | United States | $1.921B | 14.58 |
| Ardent Health (ARDT) | United States | $1.702B | 6.57 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 8.33 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.008B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.660B | 8.17 |
| CareDx (CDNA) | United States | $0.637B | 11.73 |
| Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| So-Young (SY) | China | $0.506B | 0.00 |
| Omada Health (OMDA) | $0.490B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.488B | 7.39 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.37 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.421B | 0.00 |
| Enhabit (EHAB) | United States | $0.386B | 25.40 |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Agilon Health (AGL) | United States | $0.362B | 0.00 |
| LifeMD (LFMD) | United States | $0.323B | 0.00 |
| Beauty Health (SKIN) | United States | $0.238B | 0.00 |
| Shoulder Innovations (SI) | $0.189B | 0.00 | |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.106B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.093B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |